PATHWAY-2: spironolactone for resistant hypertension.
| Title | PATHWAY-2: spironolactone for resistant hypertension. |
| Publication Type | Journal Article |
| Year of Publication | 2016 |
| Authors | Gkaliagkousi, E., Gavriilaki E., Triantafyllou A., & Douma S. |
| Journal | Lancet |
| Volume | 387 |
| Issue | 10026 |
| Pagination | 1372 |
| Date Published | 2016 Apr 02 |
| ISSN | 1474-547X |
| Keywords | Adrenergic alpha-1 Receptor Antagonists, Adrenergic beta-1 Receptor Antagonists, Bisoprolol, Doxazosin, Female, Humans, Hypertension, Male, Mineralocorticoid Receptor Antagonists, Spironolactone |
| DOI | 10.1016/S0140-6736(16)30076-9 |
| Alternate Journal | Lancet |
| PubMed ID | 27115812 |
